Search
  1. Home
  2. Southern Africa
  3. South Africa
  • News

Aspen eyes African AIDS drug market

    JOHANNESBURG

    South African generic drug maker Aspen Pharmacare says it is eyeing Africa's anti-AIDS drugs market, which has huge potential demand.

    Aspen CEO Stephen Saad said only 8 percent of the approximately 4 million people in sub-Saharan Africa who needed treatment for HIV/AIDS were receiving it.

    The local Business Day newspaper quoted him as saying, "Antiretroviral medicines are becoming a bigger and bigger part of our production - we could never have foreseen this growth."

    Aspen has approval from the US Federal Drug Administration for some of its anti-AIDS drugs, and was recently also awarded the lion's share of the South African government's antiretroviral drug tenders.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join